5,182 Shares of Astera Labs, Inc. $ALAB Purchased by Cadent Capital Advisors LLC

Posted by Geri Gentry on Oct 9th, 2026

Cadent Capital Advisors LLC acquired a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB – Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 5,182 shares of the company’s stock, valued at approximately $1,845,000.

A number of other institutional investors and hedge funds have also modified their holdings of ALAB. Farther Finance Advisors LLC lifted its position in Astera Labs by 102.8% in the third quarter. Farther Finance Advisors LLC now owns 6,043 shares of the company’s stock worth $2,151,000 after purchasing an additional 3,063 shares during the period. CoreCap Advisors LLC lifted its holdings in shares of Astera Labs by 21.0% during the 3rd quarter. CoreCap Advisors LLC now owns 749 shares of the company’s stock worth $267,000 after acquiring an additional 130 shares during the period. Cooper Financial Group acquired a new stake in shares of Astera Labs during the 3rd quarter valued at about $203,000. MRA Advisory Group increased its stake in Astera Labs by 19.6% in the third quarter. MRA Advisory Group now owns 4,299 shares of the company’s stock valued at $1,530,000 after acquiring an additional 705 shares during the period. Finally, QRG Capital Management Inc. raised its position in Astera Labs by 8.7% in the second quarter. QRG Capital Management Inc. now owns 4,775 shares of the company’s stock worth $2,306,000 after purchasing an additional 381 shares in the last quarter. 60.47% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

ALAB has been the topic of a number of recent research reports. Royal Bank Of Canada lifted their price objective on Astera Labs from $425.00 to $500.00 and gave the company an “outperform” rating in a report on Wednesday, August 5th. TD Cowen cut their target price on Astera Labs from $425.00 to $375.00 and set a “hold” rating for the company in a research report on Wednesday, August 5th. Citigroup lowered Astera Labs from a “buy” rating to a “market perform” rating in a research note on Friday. Weiss Ratings reiterated a “hold (c)” rating on shares of Astera Labs in a research note on Tuesday, August 18th. Finally, Northland Securities downgraded shares of Astera Labs from an “outperform” rating to a “market perform” rating in a research note on Friday. Ten research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $348.33.

Get Our Latest Stock Report on ALAB

Astera Labs Trading Down 1.8%

Shares of Astera Labs stock traded down $6.13 during trading on Friday, reaching $340.92. The company’s stock had a trading volume of 2,534,466 shares, compared to its average volume of 5,183,139. The stock has a 50-day moving average price of $316.82 and a two-hundred day moving average price of $290.03. The stock has a market capitalization of $59.14 billion, a P/E ratio of 168.92 and a beta of 3.68. Astera Labs, Inc. has a one year low of $97.89 and a one year high of $499.48.

Astera Labs (NASDAQ:ALAB – Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating the consensus estimate of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm had revenue of $392.40 million during the quarter, compared to analysts’ expectations of $360.85 million. During the same quarter last year, the company posted $0.44 EPS. The company’s quarterly revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, sell-side analysts anticipate that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Insider Transactions at Astera Labs

In other news, Director Stefan A. Dyckerhoff sold 8,994 shares of the company’s stock in a transaction on Wednesday, September 2nd. The stock was sold at an average price of $274.96, for a total transaction of $2,472,990.24. Following the transaction, the director owned 3,309 shares of the company’s stock, valued at $909,842.64. This represents a 73.10% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 6,801 shares of the firm’s stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.50, for a total value of $2,315,740.50. Following the completion of the transaction, the general counsel owned 96,542 shares in the company, valued at approximately $32,872,551. This represents a 6.58% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 396,059 shares of company stock worth $122,605,660 over the last ninety days. 10.40% of the stock is currently owned by insiders.

Astera Labs News Summary

Here are the key news stories impacting Astera Labs this week:

Positive Sentiment: Aries 7 expands Astera’s AI connectivity opportunity. Astera introduced what it describes as the industry’s first PCIe 7 signal-conditioning portfolio spanning copper and optical interconnects. The lineup includes retimers, redrivers, cable modules, optical drivers and transimpedance amplifiers designed for next-generation AI systems. Astera Labs Announces Aries 7
Positive Sentiment: The product launch strengthens Astera’s competitive positioning. Analysts view Aries 7 as an expansion of Astera’s PCIe portfolio and an effort to compete more directly with Marvell Technology and Credo Technology as hyperscalers increase spending on AI servers and high-speed data movement. ALAB Expands PCIe Portfolio With Aries 7
Positive Sentiment: Broader optimism about AI-chip connectivity previously lifted ALAB. Marvell’s projection that chip-connectivity could become a roughly $37 billion annual business by fiscal 2031 helped boost related semiconductor and optical-networking stocks, including Astera. Astera’s latest quarter also showed strong fundamentals, with revenue up 104.5% year over year and earnings exceeding consensus estimates.
Neutral Sentiment: Astera is increasingly viewed as an optical-infrastructure company. Its move across copper and optical links could increase its addressable market as AI clusters scale, but the company must demonstrate that the new products translate into sustained revenue and customer adoption. Astera Labs becomes an optical stock
Negative Sentiment: Valuation and concentration risks remain significant. ALAB trades at a very high earnings multiple, while Amazon Web Services reportedly represents about 70% of revenue. That dependence could magnify downside if a major customer slows AI infrastructure investment or shifts to competing solutions.
Negative Sentiment: Northland Securities downgraded the stock from “outperform” to “market perform.” The downgrade reinforces concerns that substantial growth expectations are already reflected in the share price, particularly after the stock’s large 2026 advance.

Astera Labs Profile

(Free Report)

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect and manage processors, memory, storage, and networking components in high-performance computing systems.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) smart memory controllers, Scorpio PCIe switches, Taurus Ethernet fabric switches, and Leo CXL memory connectivity products.